Home
Live
News
Create
Screeners
Insights
Kilitch Drugs
369.
90
+10.50
(+2.92%)
Market Cap
₹646.61 Cr
PE Ratio
22.57
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+2.92%
1M
-15.00%
6M
+21.66%
1Y
+12.43%
5Y
+328.62%
View Company Insights
Latest news about Kilitch Drugs
Kilitch Drugs Reschedules Rights Issue Credit and Listing Dates
Aug 25, 2025
Kilitch Drugs (India) Limited has announced changes to its rights issue timeline. The credit of Rights Equity Shares is rescheduled from August 25, 2025, to August 26, 2025, and the listing of Rights Equity Shares is moved from August 26, 2025, to August 28, 2025. The company is offering 13,98,463 equity shares at Rs. 357 per share, totaling Rs. 4,992.51 lakhs. The rights issue ratio is 2:23. Post-rights issue, the company's paid-up equity share capital will increase from 1,60,82,319 to 1,74,80,782 shares.
Kilitch Drugs Postpones Rights Issue Allotment Process by Three Days
Aug 22, 2025
Kilitch Drugs Reports Robust Q1 Results with 131% Surge in Net Profit
Aug 13, 2025
Kilitch Drugs Announces Rights Issue at ₹357 Per Share
Jul 09, 2025
Kilitch Drugs Reports Impressive Q4 Results with Soaring Profits and Revenue
May 20, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation